| Year |
Citation |
Score |
| 2024 |
Chen Z, Wang X, Jin Z, Li B, Jiang D, Wang Y, Jiang M, Zhang D, Yuan P, Zhao Y, Feng F, Lin Y, Jiang L, Wang C, Meng W, ... ... Ying J, et al. Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response. Npj Precision Oncology. 8: 73. PMID 38519580 DOI: 10.1038/s41698-024-00579-w |
0.303 |
|
| 2024 |
Cheng N, Wang B, Xu J, Xue L, Ying J. Tumor stroma ratio, tumor stroma maturity, tumor-infiltrating immune cells in relation to prognosis, and neoadjuvant therapy response in esophagogastric junction adenocarcinoma. Virchows Archiv : An International Journal of Pathology. PMID 38383941 DOI: 10.1007/s00428-024-03755-2 |
0.366 |
|
| 2024 |
Yang L, Ying J, Tao Q, Zhang Q. RNA N-methyladenosine modifications in urological cancers: from mechanism to application. Nature Reviews. Urology. PMID 38347160 DOI: 10.1038/s41585-023-00851-x |
0.477 |
|
| 2023 |
Li Z, Liu L, Wang B, Ying J, He J, Xue L. Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma. Thoracic Cancer. PMID 37466146 DOI: 10.1111/1759-7714.15043 |
0.325 |
|
| 2023 |
Zhang L, Yuan P, Cao Q, Mu J, Ying J, Guo C. Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma. Pathology Oncology Research : Por. 29: 1611204. PMID 37378074 DOI: 10.3389/pore.2023.1611204 |
0.306 |
|
| 2023 |
Zhou B, Guo W, Guo L, Li Y, Zheng Z, Huai Q, Tan F, Li Y, Xue Q, Ying J, Zhao L, Gao S, He J. Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma. Pharmacological Research. 106800. PMID 37217040 DOI: 10.1016/j.phrs.2023.106800 |
0.3 |
|
| 2023 |
Li L, Shu XS, Geng H, Ying J, Guo L, Luo J, Xiang T, Wu L, Ma BBY, Chan ATC, Zhu X, Ambinder RF, Tao Q. A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy. Cell Death and Differentiation. PMID 36813924 DOI: 10.1038/s41418-023-01129-w |
0.722 |
|
| 2023 |
Kuang Y, He Z, Li L, Wang C, Cheng X, Shi Q, Fu G, Ying J, Tao Q, Hu X. The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis targeting CHOP and BAK which is augmented by cisplatin. International Journal of Biological Sciences. 19: 120-136. PMID 36594085 DOI: 10.7150/ijbs.76345 |
0.568 |
|
| 2022 |
Dong L, Wang T, Li N, Yao H, Ying J, Wu L, Yuan G. Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Uterine Serous Carcinoma. Cells. 11. PMID 36428992 DOI: 10.3390/cells11223563 |
0.303 |
|
| 2022 |
Sun X, Zhang J, Dong J, Liu L, Li X, Xing P, Ying J, Che Y, Li J, Yang L. Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC). Translational Oncology. 25: 101538. PMID 36103754 DOI: 10.1016/j.tranon.2022.101538 |
0.345 |
|
| 2022 |
Wu X, Song P, Guo L, Ying J, Li W. Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma. Frontiers in Oncology. 12: 888951. PMID 35847947 DOI: 10.3389/fonc.2022.888951 |
0.303 |
|
| 2022 |
Wu X, Song P, Wang S, Qian Z, Ying J, Gao S, Li W. A Pan-Cancer Analysis of the Oncogenic Role of WD Repeat Domain 74 in Multiple Tumors. Frontiers in Genetics. 13: 860940. PMID 35559034 DOI: 10.3389/fgene.2022.860940 |
0.362 |
|
| 2022 |
Zhang J, Sun X, Liu L, Dong J, Deng L, Wang X, Guo Y, Ying J, Xing P, Li J, Yang L. Clinical significance of ALDH1A1 expression and its association with E-cadherin and N-cadherin in resected large cell neuroendocrine carcinoma. Translational Oncology. 19: 101379. PMID 35219092 DOI: 10.1016/j.tranon.2022.101379 |
0.319 |
|
| 2022 |
Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan AT, Chan FK, Ambinder RF, Tao Q. Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics. 12: 1736-1737. PMID 35198069 DOI: 10.7150/thno.70351 |
0.547 |
|
| 2022 |
Song P, Li W, Wu X, Qian Z, Ying J, Gao S, He J. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 35152302 DOI: 10.1007/s00262-022-03143-2 |
0.336 |
|
| 2021 |
Abubakar M, Zhang J, Ahearn TU, Koka H, Guo C, Lawrence SM, Mutreja K, Figueroa JD, Ying J, Lissowska J, Lyu N, Garcia-Closas M, Yang XR. Tumor-associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically-diverse Study Populations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33952648 DOI: 10.1158/1055-9965.EPI-21-0055 |
0.311 |
|
| 2020 |
Zhang P, Qiu T, Liu L, Lv F, Li Z, Ying J, Wang S. Conjoint Analysis of DNA Methylation for Tumor Differentiation Using Cationic Conjugated Polymers. Acs Applied Bio Materials. 3: 2867-2872. PMID 35025334 DOI: 10.1021/acsabm.0c00047 |
0.359 |
|
| 2020 |
Xue X, Huang W, Qiu T, Guo L, Ying J, Lv N. DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation. Bmc Cancer. 20: 816. PMID 32854650 DOI: 10.1186/S12885-020-07293-3 |
0.333 |
|
| 2020 |
Wang X, Wu F, Wang H, Duan X, Huang R, Tuersuntuoheti A, Su L, Yan S, Zhao Y, Lu Y, Li K, Yao J, Luo Z, Guo L, Liu J, ... ... Ying J, et al. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation. Journal of Experimental & Clinical Cancer Research : Cr. 39: 147. PMID 32746883 DOI: 10.1186/S13046-020-01632-9 |
0.332 |
|
| 2020 |
Yang L, Zhang J, Yang G, Xu H, Lin J, Shao L, Li J, Guo C, Du Y, Guo L, Li X, Han-Zhang H, Wang C, Chuai S, Ye J, ... ... Ying J, et al. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma. Theranostics. 10: 7635-7644. PMID 32685009 DOI: 10.7150/Thno.44229 |
0.371 |
|
| 2020 |
Wang S, Qu Y, Xia P, Chen Y, Zhu X, Zhang J, Wang G, Tian Y, Ying J, Fan Z. Correction: Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer. Cell Research. PMID 32541864 DOI: 10.1038/s41422-020-0352-3 |
0.321 |
|
| 2020 |
Xu H, Li W, Yang G, Li J, Yang L, Xu F, Yang Y, Ying J, Wang Y. Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 Mutations. Targeted Oncology. PMID 32418166 DOI: 10.1007/S11523-020-00722-0 |
0.342 |
|
| 2020 |
Wang S, Qu Y, Xia P, Chen Y, Zhu X, Zhang J, Wang G, Tian Y, Ying J, Fan Z. Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer. Cell Research. PMID 32367039 DOI: 10.1038/s41422-020-0312-y |
0.363 |
|
| 2020 |
Yang L, Liang H, Liu L, Guo L, Ying JM, Shi SS, Hu XS. CD56+ lymphoepithelioma-like carcinoma of the lung: A case report and literature review. World Journal of Clinical Cases. 8: 1257-1264. PMID 32337200 DOI: 10.12998/Wjcc.V8.I7.1257 |
0.324 |
|
| 2020 |
Li W, Qiu T, Dong L, Zhang F, Guo L, Ying J. Prevalence and characteristics of mutation in mismatch repair-deficient colorectal cancer. Journal of Cancer. 11: 3827-3833. PMID 32328187 DOI: 10.7150/Jca.37437 |
0.364 |
|
| 2020 |
Rong L, Wang B, Guo L, Liu X, Wang B, Ying J, Xue L, Lu N. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population. Diagnostic Pathology. 15: 27. PMID 32209107 DOI: 10.1186/S13000-020-00950-Y |
0.423 |
|
| 2020 |
Xu H, Zhang Q, Liang L, Li J, Liu Z, Li W, Yang L, Yang G, Xu F, Ying J, Zhang S, Wang Y. Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants. Cancer Medicine. PMID 32168429 DOI: 10.1002/Cam4.2984 |
0.359 |
|
| 2020 |
Li W, Liu Y, Li W, Chen L, Ying J. Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32151779 DOI: 10.1016/J.Jtho.2020.02.023 |
0.358 |
|
| 2020 |
Gao S, Li N, Gao S, Xue Q, Ying J, Wang S, Tao X, Zhao J, Mao Y, Wang B, Shao K, Lei W, Wang D, Lv F, Zhao L, et al. Neoadjuvant PD-1 inhibitor (Sintilimab) in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32036071 DOI: 10.1016/J.Jtho.2020.01.017 |
0.31 |
|
| 2020 |
Qiu T, Junling L, Zheng B, Ying J. Evaluation of the fully automated Idylla EGFR Mutation Assay in Chinese patients with lung adenocarcinoma. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E21716 |
0.311 |
|
| 2020 |
Ying J, Li W, Liu K, Xiao C, Wu S, Bao H, Wu X, Wang X, Shao Y. DNA methylation signatures predicting liver metastasis of colorectal cancer: A proof-of-concept pilot study. Journal of Clinical Oncology. 38: e16080-e16080. DOI: 10.1200/Jco.2020.38.15_Suppl.E16080 |
0.434 |
|
| 2020 |
Wang J, Zuo Y, Bai H, Duan J, Wang Z, Li W, Ying J, Han J, Tian Y, Chen Y, Shao Y. Genomic and epigenomic profiles to distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E13528 |
0.314 |
|
| 2020 |
Wang X, Ma L, Meng X, Liu J, Chai J, Yang J, Yang Z, Wu Q, Liu Y, Ying J, Wang X. Abstract P3-08-34: Development of distant recurrence risk model based on hormone receptor-positive breast cancer gene expression profiling in the Chinese population Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P3-08-34 |
0.31 |
|
| 2019 |
Qiu T, Li W, Zhang F, Wang B, Ying J. Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing. Cancer Biology & Therapy. 1-8. PMID 31651223 DOI: 10.1080/15384047.2019.1674070 |
0.464 |
|
| 2019 |
Zhao Y, Li Y, Sheng J, Wu F, Li K, Huang R, Wang X, Jiao T, Guan X, Lu Y, Chen X, Luo Z, Zhou Y, Hu H, Liu W, ... ... Ying J, et al. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Journal of Experimental & Clinical Cancer Research : Cr. 38: 379. PMID 31455383 DOI: 10.1186/S13046-019-1375-9 |
0.348 |
|
| 2019 |
Yu Y, Ma X, Zhang Y, Zhang Y, Ying J, Zhang W, Zhong Q, Zhou A, Zeng Y. Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after Neoadjuvant Chemotherapy in Gastric Cancer. Journal of Cancer. 10: 2754-2763. PMID 31258783 DOI: 10.7150/Jca.31755 |
0.306 |
|
| 2019 |
Guo L, Song P, Xue X, Guo C, Han L, Fang Q, Ying J, Gao S, Li W. Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 31145232 DOI: 10.1097/Cji.0000000000000275 |
0.339 |
|
| 2019 |
Zhang X, Liang Z, Wang S, Lu S, Song Y, Cheng Y, Ying J, Liu W, Hou Y, Li Y, Liu Y, Hou J, Liu X, Shao J, Tai Y, et al. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology. Cancer Biology & Medicine. 16: 189-204. PMID 31119060 DOI: 10.20892/J.Issn.2095-3941.2018.0142 |
0.325 |
|
| 2019 |
Song P, Zhang F, Li Y, Yang G, Li W, Ying J, Gao S. Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer. Cancer Medicine. PMID 30843662 DOI: 10.1002/Cam4.2043 |
0.363 |
|
| 2019 |
Xu Z, Xing P, Ma D, Zhu Y, Ying J, Li J. [Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 22: 111-117. PMID 30827328 DOI: 10.3779/J.Issn.1009-3419.2019.02.06 |
0.305 |
|
| 2019 |
Yu Y, Ying J, Zhang W, Li W, Sun Y, Yang L, Cui C, Zeng Y, Zhou A. Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study. Asia-Pacific Journal of Clinical Oncology. PMID 30693649 DOI: 10.1111/Ajco.13130 |
0.302 |
|
| 2019 |
Zhou SY, Xue Q, Ying JM, Hu XS, Yang JL, Lin H, Shi YK. [The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 41: 50-55. PMID 30678417 DOI: 10.3760/Cma.J.Issn.0253-3766.2019.01.009 |
0.389 |
|
| 2019 |
Li N, Ying J, Tao X, Zhang F, Zhao Z, Ling Y, Gao Y, Zhao J, Xue Q, Mao Y, Lei W, Wu N, Wang S, Duan J, Gao Y, et al. Efficacy and safety of neoadjuvant PD-1 blockade with sintilimab in resectable squamous non-small cell lung cancer (sqNSCLC). Journal of Clinical Oncology. 37: 8531-8531. DOI: 10.1200/Jco.2019.37.15_Suppl.8531 |
0.338 |
|
| 2019 |
Xu J, Shen L, Zhou Z, Li J, Bai C, Chi Y, Li Z, Xu N, Jia R, Li E, Liu T, Bai Y, Yuan Y, Li X, Wang X, ... ... Ying J, et al. Efficacy and safety of surufatinib in patients with well-differentiated advanced extrapancreatic neuroendocrine tumors (NETs): Results from the randomized phase III study (SANET-ep) Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz394.073 |
0.336 |
|
| 2019 |
Li N, Ying J, Tao X, Zhang F, Zhao Z, Ling Y, Gao Y, Zhao J, Xue Q, Mao Y, Lei W, Wu N, Wang S, Duan J, Gao Y, et al. JCSE01.10 Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC) Journal of Thoracic Oncology. 14: S128-S129. DOI: 10.1016/J.Jtho.2019.08.268 |
0.336 |
|
| 2019 |
Mu Y, Xing P, Li Y, Hao X, Ying J, Li J. P2.16-08 Clinical Characteristics and Outcomes of Patients with BRAF Mutated Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1875 |
0.365 |
|
| 2019 |
Wang Y, Ying J, Yang L, Zhang J, Zhang T, Lin J. P2.11-31 DNA Methylation Markers for Prediction of Recurrence in Stage I Non-Small Cell Lung Cancers Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1731 |
0.401 |
|
| 2019 |
Li N, Ying J, Tao X, Zhang F, Zhao Z, Ling Y, Gao Y, Zhao J, Xue Q, Mao Y, Lei W, Wu N, Wang S, Duan J, Wang Z, et al. P1.18-06 Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1322 |
0.337 |
|
| 2018 |
Xue LY, Qin XM, Liu Y, Liang J, Lin H, Xue XM, Zou SM, Zhang MY, Zhang BH, Hui ZG, Zhao ZT, Ren LQ, Zhang YM, Liu XY, Yuan YL, ... Ying JM, et al. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma. World Journal of Gastroenterology. 24: 5154-5166. PMID 30568392 DOI: 10.3748/Wjg.V24.I45.5154 |
0.423 |
|
| 2018 |
Li W, Song P, Guo L, Liu X, Guo C, Ying J, Gao S. Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients. Thoracic Cancer. PMID 30536734 DOI: 10.1111/1759-7714.12929 |
0.375 |
|
| 2018 |
Song P, Guo L, Li W, Zhang F, Ying J, Gao S. Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non-Small Cell Lung Cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 30407231 DOI: 10.1097/Cji.0000000000000249 |
0.316 |
|
| 2018 |
Wang J, Wang D, Niu X, Wang Z, Song CL, Huang Z, Chen KN, Duan J, Bai H, Xu J, Zhao J, Wang Y, Zhuo M, Xie XS, Kang X, ... ... Ying J, et al. Multiregion sequencing reveals the genetic heterogeneity and evolutionary history of osteosarcoma and matched pulmonary metastases. Cancer Research. PMID 30389703 DOI: 10.1158/0008-5472.Can-18-1086 |
0.435 |
|
| 2018 |
Zou SM, Li WH, Wang WM, Li WB, Shi SS, Ying JM, Lyu N. The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing. Journal of Cancer Research and Clinical Oncology. PMID 30171333 DOI: 10.1007/S00432-018-2742-1 |
0.346 |
|
| 2018 |
Li Y, Gao L, Ma D, Qiu T, Li W, Li W, Guo L, Xing P, Liu B, Deng L, Fu J, Li J, Yu Y, Ying J. Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas. Lung Cancer (Amsterdam, Netherlands). 122: 113-119. PMID 30032818 DOI: 10.1016/J.Lungcan.2018.06.001 |
0.336 |
|
| 2018 |
Wang L, Fan Y, Zhang L, Li L, Kuang G, Luo C, Li C, Xiang T, Tao Q, Zhang Q, Ying J. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701453RR. PMID 29957056 DOI: 10.1096/Fj.201701453Rr |
0.654 |
|
| 2018 |
Jia J, Zhao L, Guo H, Zhao H, Zhang Z, Guo L, Ying J. [The application of conventional smears and liquid-based cytologic slides of lymphatic metastasis specimens of lung adenocarcinoma acquired by fine needle aspiration to detect the expression of anaplastic lymphoma kinase protein]. Chinese Journal of Oncology. 40: 422-427. PMID 29936767 DOI: 10.3760/Cma.J.Issn.0253-3766.2018.06.005 |
0.336 |
|
| 2018 |
Xu H, Xu F, Zhu W, Ying J, Wang Y. Comparing first-line treatment patterns and clinical outcomes of patients with pan-negative advanced non-squamous non-small cell lung cancer. Thoracic Cancer. PMID 29917332 DOI: 10.1111/1759-7714.12777 |
0.364 |
|
| 2018 |
Su K, Gao S, Ying J, Zou S, He J. Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B. The Journal of Thoracic and Cardiovascular Surgery. PMID 29576263 DOI: 10.1016/J.Jtcvs.2018.01.010 |
0.33 |
|
| 2018 |
Li Y, Zhang T, Zhang J, Li W, Yuan P, Xing P, Zhang Z, Chuai S, Li J, Ying J. Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants. Lung Cancer (Amsterdam, Netherlands). 118: 128-133. PMID 29571990 DOI: 10.1016/J.Lungcan.2018.01.026 |
0.357 |
|
| 2018 |
Li W, Qiu T, Guo L, Ling Y, Gao Y, Ying J, He J. Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment. Cancer Letters. PMID 29524556 DOI: 10.1016/J.Canlet.2018.03.005 |
0.317 |
|
| 2018 |
Li W, Qiu T, Ling Y, Gao S, Ying J. Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions. Molecular Oncology. PMID 29518290 DOI: 10.1002/1878-0261.12190 |
0.436 |
|
| 2018 |
Liu Y, Hao X, Hu X, Li J, Wang Y, Wang H, Xing P, Li W, Ying J, Han X, Shi Y. Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report. Thoracic Cancer. PMID 29411527 DOI: 10.1111/1759-7714.12596 |
0.305 |
|
| 2018 |
Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan AT, Chan FK, Ambinder RF, Tao Q. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas. Theranostics. 8: 61-77. PMID 29290793 DOI: 10.7150/Thno.20893 |
0.673 |
|
| 2018 |
Yu Y, Zeng Y, Zhou A, Ma X, Zhang Y, Shen Z, Ying J, Zhang W, Zhong Q. Effects of neoadjuvant chemotherapy on immune microenvironment and clinical outcomes in locally advanced gastric cancer. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E24133 |
0.363 |
|
| 2018 |
Ying J, Yuan P, Li Y, Jiang L, Liu Y, Junling L. Multicenter study for the correlation among PD-L1 antibodies, tumor mutation burden (TMB) and lung immune prognostic index (lipi) in Chinese patients with advanced lung adenocarcinoma. Journal of Clinical Oncology. 36: e21218-e21218. DOI: 10.1200/Jco.2018.36.15_Suppl.E21218 |
0.314 |
|
| 2018 |
Yu Y, Zeng Y, Ying J, Zhang W, Zhou A. Outcome of chemotherapy with or without targeted therapy in metastatic colorectal cancer with deficient mismatch repair phenotype: A cohort study in a single center. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E15669 |
0.303 |
|
| 2018 |
Wei Q, He Q, Xu Q, Li J, Chen L, Luo C, Ying J. The correlation between RhoA, CDH1 expression and clinicopathological characteristics in Chinese gastric cancer patients. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy151.075 |
0.327 |
|
| 2018 |
Li L, Guo C, Guo L, Dai H, Ying J, Gao Y. P2.09-04 PD-L1 Expression in Primary Lung Adenocarcinoma and its Relation with EGFR / KRAS Mutation and Clinicopathological Features Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.1301 |
0.323 |
|
| 2018 |
Yuan P, Li Y, Jiang L, Liu Y, Liu W, Ying J. P2.01-114 The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.1169 |
0.304 |
|
| 2017 |
Qiu T, Li W, Zhang T, Xing P, Huang W, Wang B, Chu L, Guo L, Liu X, Li Y, Ying J, Li J. Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer. Clinical Lung Cancer. PMID 29338938 DOI: 10.1016/J.Cllc.2017.12.006 |
0.391 |
|
| 2017 |
Zhao H, Qiu T, Guo H, Ying J, Li J, Zhang Z. Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma. Oncotarget. 8: 106685-106692. PMID 29290981 DOI: 10.18632/Oncotarget.22530 |
0.335 |
|
| 2017 |
Huang W, Xue X, Shan L, Qiu T, Guo L, Ying J, Lu N. Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma. Bmc Cancer. 17: 815. PMID 29202805 DOI: 10.1186/S12885-017-3810-7 |
0.459 |
|
| 2017 |
Shao B, Feng Y, Zhang H, Yu F, Li Q, Tan C, Xu H, Ying J, Li L, Yang D, Peng W, Tang J, Li S, Ren G, Tao Q, et al. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer. Journal of Cellular and Molecular Medicine. PMID 29193730 DOI: 10.1111/Jcmm.13404 |
0.628 |
|
| 2017 |
Qin Q, Yang L, Sun YK, Ying JM, Song Y, Zhang W, Wang JW, Zhou AP. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival. Chronic Diseases and Translational Medicine. 3: 51-59. PMID 29063056 DOI: 10.1016/J.Cdtm.2017.02.004 |
0.316 |
|
| 2017 |
Li W, Qiu T, Guo L, Ying J. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing. Cancer Letters. PMID 28942013 DOI: 10.1016/J.Canlet.2017.09.014 |
0.401 |
|
| 2017 |
Ma W, Guo L, Shan L, Liu X, Lyu N, Ying J. Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis. Scientific Reports. 7: 10961. PMID 28887531 DOI: 10.1038/S41598-017-11453-0 |
0.352 |
|
| 2017 |
Liang Z, Cheng Y, Chen Y, Hu Y, Liu WP, Lu Y, Wang J, Wang Y, Wu G, Ying JM, Zhang HL, Zhang XC, Wu YL. EGFR T790M ctDNA testing platforms and their role as companion diagnostics: correlation with clinical outcomes to EGFR-TKIs. Cancer Letters. PMID 28642172 DOI: 10.1016/J.Canlet.2017.06.008 |
0.316 |
|
| 2017 |
Liang Z, Cheng Y, Chen Y, Liu W, Lu Y, Wang J, Wu G, Ying J, Zhang X, Wu Y. Detect T790M in cell free tumor DNA of Chinese advanced non-small cell lung cancer adenocarcinoma patients by different platforms and evaluate clinical outcomes of T790M positive patients with osimertinib monotherapy. Journal of Clinical Oncology. 35: TPS9104-TPS9104. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps9104 |
0.396 |
|
| 2017 |
Ying J, Li Y, Zhang T, Li W, Xing P, Zhang J, Junling L. Response to crizotinib in advanced ALK-rearranged NSCLCs with different variants and abundance of ALK-fusion alleles. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E20651 |
0.345 |
|
| 2017 |
Ying J, Gao L, Li Y, Liu B, Deng L, Li L, Ma D, Li J, Jiang Z. Targeted DNA- and RNA-based next-generation sequencing for identifying MET exon 14 alterations in pulmonary sarcomatoid carcinoma. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E20591 |
0.314 |
|
| 2016 |
Zhang J, Guo L, Liu X, Li W, Ying J. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma. Oncotarget. PMID 28052014 DOI: 10.18632/Oncotarget.14382 |
0.352 |
|
| 2016 |
Wang P, Shan L, Xue L, Zheng B, Ying J, Lu N. Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis. Oncotarget. PMID 27974698 DOI: 10.18632/Oncotarget.13847 |
0.384 |
|
| 2016 |
Yang L, Ling Y, Guo L, Ma D, Xue X, Wang B, Li J, Ying J. Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center large-scale investigation of 1, 504 Chinese Han patients. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 28: 495-502. PMID 27877008 DOI: 10.21147/J.Issn.1000-9604.2016.05.04 |
0.344 |
|
| 2016 |
Huang W, Qiu T, Zeng L, Zheng B, Ying J, Feng X. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms. Oncotarget. PMID 27823979 DOI: 10.18632/Oncotarget.13058 |
0.396 |
|
| 2016 |
Ling Y, Yang X, Li W, Li Z, Yang L, Qiu T, Guo L, Dong L, Li L, Ying J, Lin D. Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer. Oncotarget. PMID 27418143 DOI: 10.18632/Oncotarget.10594 |
0.364 |
|
| 2016 |
Wang X, Niu H, Fan Q, Lu P, Ma C, Liu W, Liu Y, Li W, Hu S, Ling Y, Guo L, Ying J, Huang J. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma. Oncotarget. PMID 27013591 DOI: 10.18632/Oncotarget.8271 |
0.396 |
|
| 2016 |
Huang J, Fan Q, Lu P, Ying J, Ma C, Liu W, Liu Y, Tan F, Sun Y. Icotinib in pretreated, advanced esophageal squamous cell carcinoma patients with EGFR over-expression or amplification: a single-arm, multicenter, phase 2 study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26980473 DOI: 10.1016/J.Jtho.2016.02.020 |
0.374 |
|
| 2016 |
Sun H, Sun X, Zhai X, Guo J, Liu Y, Ying J, Wang Z. Body mass index and exon 19 mutation as factors predicting the therapeutic efficacy of gefitinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer. Thoracic Cancer. 7: 61-65. PMID 26816540 DOI: 10.1111/1759-7714.12275 |
0.346 |
|
| 2016 |
Ying J, Li W, Guo L, Junling L, Lu N. Atypical negative ALK FISH accompanied by immunohistochemistry positivity harbored various ALK rearrangements in NSCLC patients and respond to targeted therapy. Journal of Clinical Oncology. 34: e20506-e20506. DOI: 10.1200/Jco.2016.34.15_Suppl.E20506 |
0.354 |
|
| 2015 |
Li W, Zhang Z, Guo L, Qiu T, Ling Y, Cao J, Guo H, Zhao H, Li L, Ying J. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer. Oncotarget. PMID 26789109 DOI: 10.18632/Oncotarget.6671 |
0.367 |
|
| 2015 |
Ying J, Lin C, Wu J, Guo L, Qiu T, Ling Y, Shan L, Zhou H, Zhao D, Wang J, Liang J, Zhao J, Jiao Y, Lu N, Zhao H. Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population. Plos One. 10: e0144731. PMID 26678488 DOI: 10.1371/Journal.Pone.0144731 |
0.375 |
|
| 2015 |
Li W, Qiu T, Ling Y, Guo L, Li L, Ying J. Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations. Oncotarget. PMID 26530529 DOI: 10.18632/Oncotarget.5551 |
0.424 |
|
| 2015 |
Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, et al. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Oncotarget. PMID 26376676 DOI: 10.18632/Oncotarget.5578 |
0.447 |
|
| 2015 |
Song W, Liu W, Zhao H, Li S, Guan X, Ying J, Zhang Y, Miao F, Zhang M, Ren X, Li X, Wu F, Zhao Y, Tian Y, Wu W, et al. Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway. Nature Communications. 6: 8022. PMID 26300397 DOI: 10.1038/ncomms9022 |
0.338 |
|
| 2015 |
Shan L, Wang Z, Guo L, Sun H, Qiu T, Ling Y, Li W, Li L, Liu X, Zheng B, Lu N, Ying J. Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients. Lung Cancer (Amsterdam, Netherlands). PMID 26141217 DOI: 10.1016/J.Lungcan.2015.06.008 |
0.324 |
|
| 2015 |
Wang W, Wang J, Li M, Ying J, Jing H. 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma. International Journal of Molecular Medicine. PMID 26133246 DOI: 10.3892/ijmm.2015.2269 |
0.339 |
|
| 2015 |
Shan L, Qiu T, Ling Y, Guo L, Zheng B, Wang B, Li W, Li L, Ying J. Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma. Plos One. 10: e0130447. PMID 26102513 DOI: 10.1371/Journal.Pone.0130447 |
0.308 |
|
| 2015 |
Liu Q, Jin J, Ying J, Cui Y, Sun M, Zhang L, Fan Y, Xu B, Zhang Q. Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target. Oncotarget. PMID 26093088 DOI: 10.18632/Oncotarget.4256 |
0.546 |
|
| 2015 |
Zhang Z, Yuan P, Guo H, Zhao L, Ying J, Wang M, Zhao H, Pan Q, Xu B. Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China. Medicine. 94: e981. PMID 26091472 DOI: 10.1097/Md.0000000000000981 |
0.304 |
|
| 2015 |
Li W, Zhi W, Zou S, Qiu T, Ling Y, Shan L, Shi S, Ying J. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations. Plos One. 10: e0128202. PMID 26042813 DOI: 10.1371/Journal.Pone.0128202 |
0.392 |
|
| 2015 |
Shan L, Jiang P, Xu F, Zhang W, Guo L, Wu J, Zeng Y, Jiao Y, Ying J. BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: e37-9. PMID 26001147 DOI: 10.1097/Jto.0000000000000467 |
0.302 |
|
| 2015 |
Liu Q, Jin J, Ying J, Sun M, Cui Y, Zhang L, Xu B, Fan Y, Zhang Q. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. International Journal of Molecular Sciences. 16: 10636-49. PMID 25970749 DOI: 10.3390/Ijms160510636 |
0.564 |
|
| 2015 |
Li W, Qiu T, Zhi W, Shi S, Zou S, Ling Y, Shan L, Ying J, Lu N. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. Bmc Cancer. 15: 340. PMID 25929517 DOI: 10.1186/S12885-015-1345-3 |
0.389 |
|
| 2015 |
Qiu T, Lu H, Guo L, Huang W, Ling Y, Shan L, Li W, Ying J, Lv N. Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay. Scientific Reports. 5: 9211. PMID 25784606 DOI: 10.1038/Srep09211 |
0.381 |
|
| 2015 |
Zhu X, Shan L, Wang F, Wang J, Wang F, Shen G, Liu X, Wang B, Yuan Y, Ying J, Yang H. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer. Breast Cancer Research and Treatment. 150: 479-86. PMID 25783183 DOI: 10.1007/S10549-015-3338-Y |
0.368 |
|
| 2015 |
Zhang L, Zhang Q, Li L, Wang Z, Ying J, Fan Y, He Q, Lv T, Han W, Li J, Yang Y, Xu B, Wang L, Liu Q, Sun Y, et al. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine (Berlin, Germany). 93: 691-701. PMID 25648635 DOI: 10.1007/S00109-015-1255-5 |
0.772 |
|
| 2015 |
Xu B, Zhang L, Luo C, Qi Y, Cui Y, Ying JM, Zhang Q, Jin J. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma. International Journal of Molecular Sciences. 16: 1051-65. PMID 25569086 DOI: 10.3390/Ijms16011051 |
0.564 |
|
| 2014 |
Lu H, Qiu T, Ying J, Guo C, Lyn N. [Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma]. Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 43: 794-8. PMID 25623974 DOI: 10.3760/Cma.J.Issn.0529-5807.2014.12.002 |
0.366 |
|
| 2014 |
Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N, Xu B. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. Plos One. 9: e112765. PMID 25393310 DOI: 10.1371/Journal.Pone.0112765 |
0.376 |
|
| 2014 |
Zhang Q, Zhang L, Li L, Wang Z, Ying J, Fan Y, Xu B, Wang L, Liu Q, Chen G, Tao Q, Jin J. Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. Cancer Letters. 354: 227-34. PMID 25109451 DOI: 10.1016/J.Canlet.2014.07.040 |
0.809 |
|
| 2014 |
Wang L, Shan L, Zhang S, Ying J, Xue L, Yuan Y, Xie Y, Lu N. PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma. Plos One. 9: e103021. PMID 25054828 DOI: 10.1371/Journal.Pone.0103021 |
0.41 |
|
| 2014 |
Lyu X, Huang J, Liu J, Wang W, Su Y, Zhang W, Sun Y, Ying J, Wang J, Sun Y. [Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 36: 346-50. PMID 25030589 DOI: 10.3760/Cma.J.Issn.0253-3766.2014.05.006 |
0.447 |
|
| 2014 |
Shan L, Lian F, Guo L, Yang X, Ying J, Lin D. Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement. Diagnostic Pathology. 9: 3. PMID 24422905 DOI: 10.1186/1746-1596-9-3 |
0.316 |
|
| 2014 |
Choi GC, Li J, Wang Y, Li L, Zhong L, Ma B, Su X, Ying J, Xiang T, Rha SY, Yu J, Sung JJ, Tsao SW, Chan AT, Tao Q. The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. Molecular Cancer Research : McR. 12: 228-38. PMID 24184540 DOI: 10.1158/1541-7786.Mcr-13-0195 |
0.69 |
|
| 2014 |
Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, Chan AT, Ambinder RF, Guo Y, Tao Q. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and Molecular Life Sciences : Cmls. 71: 2179-92. PMID 24158497 DOI: 10.1007/S00018-013-1485-Z |
0.764 |
|
| 2014 |
Li H, Li J, Su Y, Fan Y, Guo X, Li L, Su X, Rong R, Ying J, Mo X, Liu K, Zhang Z, Yang F, Jiang G, Wang J, et al. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. Oncogene. 33: 3109-18. PMID 23893243 DOI: 10.1038/Onc.2013.282 |
0.817 |
|
| 2013 |
Ying J, Guo L, Qiu T, Shan L, Ling Y, Liu X, Lu N. Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 24: 2589-2593. PMID 23904459 DOI: 10.1093/Annonc/Mdt295 |
0.311 |
|
| 2013 |
Shu XS, Li L, Ji M, Cheng Y, Ying J, Fan Y, Zhong L, Liu X, Tsao SW, Chan AT, Tao Q. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis. 34: 1984-93. PMID 23677067 DOI: 10.1093/Carcin/Bgt165 |
0.827 |
|
| 2013 |
Shan L, Ying J, Lu N. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population. Diagnostic Pathology. 8: 76. PMID 23656792 DOI: 10.1186/1746-1596-8-76 |
0.336 |
|
| 2013 |
Li JS, Ying JM, Wang XW, Wang ZH, Tao Q, Li LL. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. Chinese Journal of Cancer. 32: 3-11. PMID 22572016 DOI: 10.5732/Cjc.011.10381 |
0.627 |
|
| 2013 |
Huang W, Qiu T, Ling Y, Shi S, Guo L, Zheng B, Lü N, Ying J. Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma Chinese Journal of Pathology. 42: 655-659. DOI: 10.3760/Cma.J.Issn.0529-5807.2013.10.003 |
0.329 |
|
| 2012 |
Qiu T, Ling Y, Chen Z, Shan L, Guo L, Lü N, Ying JM. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas]. Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 41: 599-602. PMID 23157827 DOI: 10.3760/Cma.J.Issn.0529-5807.2012.09.006 |
0.311 |
|
| 2012 |
Ling Y, Ying JM, Qiu T, Shan L, Guo L, Lü N. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma]. Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 41: 590-4. PMID 23157825 DOI: 10.3760/Cma.J.Issn.0529-5807.2012.09.004 |
0.355 |
|
| 2012 |
Zhao H, Li Q, Wang J, Su X, Ng KM, Qiu T, Shan L, Ling Y, Wang L, Cai J, Ying J. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. Plos One. 7: e49683. PMID 23152928 DOI: 10.1371/Journal.Pone.0049683 |
0.452 |
|
| 2012 |
Ying J, Shan L, Li J, Zhong L, Xue L, Zhao H, Li L, Langford C, Guo L, Qiu T, Lu N, Tao Q. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis. Plos One. 7: e39797. PMID 22761904 DOI: 10.1371/Journal.Pone.0039797 |
0.583 |
|
| 2012 |
Cheng Y, Liang P, Geng H, Wang Z, Li L, Cheng SH, Ying J, Su X, Ng KM, Ng MH, Mok TS, Chan AT, Tao Q. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Molecular Cancer Research : McR. 10: 925-36. PMID 22679109 DOI: 10.1158/1541-7786.Mcr-11-0594 |
0.682 |
|
| 2012 |
Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, Tan J, Cao Y, Tsao SW, Srivastava G, Chan ATC, Tao Q. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/Β-catenin signaling and silenced in common carcinomas Oncogene. 31: 3901-3912. PMID 22139084 DOI: 10.1038/Onc.2011.541 |
0.819 |
|
| 2012 |
Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MYY, Shen B, Cheng ASL, Ying J, Tao Q, Sung JJY, Kung HF, Yu J. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients Oncogene. 31: 3419-3430. PMID 22105368 DOI: 10.1038/Onc.2011.511 |
0.674 |
|
| 2011 |
Shu XS, Geng H, Li L, Ying J, Ma C, Wang Y, Poon FF, Wang X, Ying Y, Yeo W, Srivastava G, Tsao SW, Yu J, Sung JJ, Huang S, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors. Plos One. 6: e27346. PMID 22087297 DOI: 10.1371/Journal.Pone.0027346 |
0.778 |
|
| 2011 |
Choi GC, Wang Y, Li J, Li L, Ying J, Ma BB, Tao Q, Chan AT. Abstract 2190:ADAMTS8at 11q25 is a tumor suppressor antagonizing Ras-signaling and methylated in multiple carcinomas Cancer Research. 71: 2190-2190. DOI: 10.1158/1538-7445.Am2011-2190 |
0.68 |
|
| 2010 |
Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, et al. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. The American Journal of Pathology. 177: 1480-90. PMID 20709797 DOI: 10.2353/Ajpath.2010.100052 |
0.786 |
|
| 2010 |
Zhang Q, Ying J, Li J, Fan Y, Poon FF, Ng KM, Tao Q, Jin J. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage. The Journal of Urology. 184: 731-7. PMID 20639048 DOI: 10.1016/J.Juro.2010.03.108 |
0.804 |
|
| 2010 |
Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biology & Therapy. 10: 617-24. PMID 20603606 DOI: 10.4161/Cbt.10.6.12609 |
0.798 |
|
| 2010 |
Ying J, Guo L, Liu X, Qiu T, Lü N. [Automated silver-enhanced in situ hybridization detection assay for human epidermal growth factor receptor 2 gene status determination in breast cancer]. National Medical Journal of China. 90: 1674-1677. DOI: 10.3760/Cma.J.Issn.0376-2491.2010.24.005 |
0.334 |
|
| 2009 |
Ying J, Poon FF, Yu J, Geng H, Wong AH, Qiu GH, Goh HK, Rha SY, Tian L, Chan AT, Sung JJ, Tao Q. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. British Journal of Cancer. 100: 663-9. PMID 19156137 DOI: 10.1038/Sj.Bjc.6604888 |
0.618 |
|
| 2009 |
Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 136: 640-51.e1. PMID 19084528 DOI: 10.1053/J.Gastro.2008.10.050 |
0.624 |
|
| 2008 |
Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, et al. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene. 27: 5267-76. PMID 18469857 DOI: 10.1038/Onc.2008.147 |
0.663 |
|
| 2008 |
Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 55-61. PMID 18172252 DOI: 10.1158/1078-0432.Ccr-07-1644 |
0.566 |
|
| 2008 |
Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, Fields CR, Delmas AL, Liu X, Qiu J, Robertson KD. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Human Molecular Genetics. 17: 690-709. PMID 18029387 DOI: 10.1093/Hmg/Ddm341 |
0.569 |
|
| 2007 |
Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood. 110: 4130-2. PMID 18024799 DOI: 10.1182/Blood-2007-06-094870 |
0.596 |
|
| 2007 |
Ying J, Li H, Murray P, Gao Z, Chen YW, Wang Y, Lee KY, Chan AT, Ambinder RF, Srivastava G, Tao Q. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas. Epigenetics. 2: 15-21. PMID 17965626 DOI: 10.4161/Epi.2.1.3883 |
0.663 |
|
| 2007 |
Tedoldi S, Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, et al. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. The Journal of Pathology. 213: 429-40. PMID 17935142 DOI: 10.1002/Path.2242 |
0.543 |
|
| 2007 |
Bose S, Starczynski J, Chukwuma M, Baumforth K, Wei W, Morgan S, Byrd P, Ying J, Grundy R, Mann JR, Tao Q, Taylor AM, Murray PG, Stankovic T. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. The Journal of Pathology. 213: 329-36. PMID 17876757 DOI: 10.1002/Path.2232 |
0.572 |
|
| 2007 |
Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, Cullen PJ, Tao Q. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proceedings of the National Academy of Sciences of the United States of America. 104: 12353-8. PMID 17640920 DOI: 10.1073/Pnas.0700153104 |
0.513 |
|
| 2007 |
Jin H, Wang X, Ying J, Wong AH, Li H, Lee KY, Srivastava G, Chan AT, Yeo W, Ma BB, Putti TC, Lung ML, Shen ZY, Xu LY, Langford C, et al. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene. 26: 7490-8. PMID 17546048 DOI: 10.1038/Sj.Onc.1210559 |
0.679 |
|
| 2007 |
Law FB, Chen YW, Wong KY, Ying J, Tao Q, Langford C, Lee PY, Law S, Cheung RW, Chui CH, Tsao SW, Lam KY, Wong J, Srivastava G, Tang JC. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene. 26: 5877-88. PMID 17384685 DOI: 10.1038/Sj.Onc.1210390 |
0.613 |
|
| 2007 |
Feng X, Li L, Gao Y, Zhang J, Ying J, Xiao T, Gao J, Liu X, Sun Y, Cheng S. Fhit protein expression in lung cancer studied by high-throughput tissue microarray. Bulletin Du Cancer. 94: E8-11. PMID 17371765 |
0.317 |
|
| 2007 |
Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, Lim CY, Wang Y, Marafioti T, Mason DY, Ambinder RF, Chan AT, Tao Q. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. British Journal of Haematology. 136: 829-32. PMID 17341268 DOI: 10.1111/J.1365-2141.2007.06512.X |
0.602 |
|
| 2007 |
Zhang Q, Ying J, Zhang K, Li H, Ng KM, Zhao Y, He Q, Yang X, Xin D, Liao SK, Tao Q, Jin J. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. Cancer Letters. 249: 220-6. PMID 17029774 DOI: 10.1016/J.Canlet.2006.08.019 |
0.651 |
|
| 2006 |
Ying J, Li H, Cui Y, Wong AH, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia. 20: 1173-5. PMID 16572203 DOI: 10.1038/Sj.Leu.2404193 |
0.58 |
|
| 2006 |
Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan ATC, Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation Oncogene. 25: 1070-1080. PMID 16247458 DOI: 10.1038/Sj.Onc.1209154 |
0.636 |
|
| 2005 |
Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors Clinical Cancer Research. 11: 6442-6449. PMID 16166418 DOI: 10.1158/1078-0432.Ccr-05-0267 |
0.675 |
|
| 2004 |
Ying J, Srivastava G, Gao Z, Zhang X, Murray P, Ambinder R, Tao Q. Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas. Blood. 103: 743-6. PMID 14702288 DOI: 10.1182/Blood-2003-09-3193 |
0.613 |
|
| Show low-probability matches. |